|| Print ||
|Articles - July/August 2013|
|Monday, July 08, 2013|
Page 2 of 4
In general, tenure-track professors are obsessed with the number of papers they publish. Traditionally, it’s the best path to getting the prized tenure contract.
Not in the Goforth lab, a small space in a nondescript building on the Portland State University campus where Andrea Goforth, an inorganic chemist, and her team of postgraduate students do their work. Hired by PSU as a junior professor at a time when federal grant money hasn’t kept pace with demand, Goforth isn’t as focused on churning out papers as might be expected. Instead she’s been able to follow her two current research passions: biomedical imaging agents at the nanoscale and the novel properties of the chemical element bismuth, the active ingredient in Pepto-Bismol.
Although they seem disparate, Goforth’s two enthusiasms actually feed each other. Goforth, 34, has a patent on her discoveries regarding how tiny bismuth particles, which are radiopaque — visible on X-ray — may also be easier on the human body than barium and suitable for use in medical devices.
What is also novel about Goforth’s discovery is how quickly she’s turned it into a product idea — add-ins to surgical sponges — and parlayed the idea into a company called Hawthorne Materials Corp.
“It’s not typical of chemists in an academic environment to be thinking so much about commercialization,” Goforth admits. “With federal funding as low as it has been, though…academic institutions stubbornly stuck on getting Fed money are starting to realize we need to collaborate locally.”
Goforth has done that — she heaped praise on ONAMI for connecting her to electron microscopes integral to her research. In addition to the enthusiastic engagement of her postgraduate student Anna Brown, the university’s MBA students and technology transfer office helped Goforth zero in on market potential and appropriate products to be created from the radiopaque bismuth particles. Toxicity testing of the “Bismarkers,” as they are currently called, is proceeding.
Goforth says her partners know marketing Bismarkers will never be of higher priority to her than doing basic nanoscience. Yet she’s also clear that pursuing new commercialization possibilities, is, in a sense, a part of her job, much like teaching the next generation of scientists and publishing her research findings. As a transplanted Tennessean, she loves Portland and hopes that Oregon can develop its research in nanotech into some kind of cluster or hub.
“Relative to Seattle’s prominence, nanobiotech might be a bit more difficult to cultivate,” she says. “With Intel here, nano in device integration is more likely. Maybe we could be the happy middle ground and develop a bit of a hub for both.”
Goforth’s partner, Brown, always thought she would be academically bound. Now nanotechnology and the bismuth research are changing her trajectory.
“The world doesn’t need more professors,” she says. “I’m hoping instead I can translate that high-risk, high-reward startup mentality of the software industry to nanomaterials. That feels like a career calling.”
What’s good for her could also be good for Oregon. “Maybe there’s no way we’ll compete with Silicon Valley,” says Brown. “But anchoring a nanomaterials industry into the Pacific Northwest? From my little bit of experience with the Oregon Angel Fund, that seems to be what investors are getting excited about.”
Wednesday, October 08, 2014
BY LINDA BAKER | OB EDITOR
A Design Week panel discussion raises questions about how innovative we really are.
Friday, October 24, 2014
How does your workplace stack up against competitors? How can you improve workplace practices to help recruit and retain employees? Find out by taking our 100 Best Companies to Work for in Oregon survey!
Wednesday, October 22, 2014
BY JASON NORRIS
Historically, when the leaves fall, so do the markets. This year, earnings, Europe, energy and Ebola have in common? Beyond alliteration, they are four factors that the investors are pointing to for this year’s seasonal volatility.
Wednesday, October 22, 2014
BY KIM MOORE
Fred Ziari aims to feed the global population.
Friday, October 17, 2014
BY TOM COX | OB BLOGGER
How can you move from a command-and-control leadership model to one of true empowerment and accountability? David Marquet did, and he took notes along the way.
Wednesday, October 22, 2014
BY JOE ROJAS-BURKE
The black soldier fly’s larvae are among the most ravenous and least picky eaters on earth.
Thursday, October 02, 2014
More than 5,500 employees from 180 organizations throughout the state participated in the 100 Best Nonprofits to Work for in Oregon project.
|A Complex Portrait: Immigration, Jobs and the Economy|
|Woman of Steel|
|Kill the Meeting|
|Ferguson bakery saved by crowdfunding|
|Obamacare yields more than 1M applicants in first week of open enrollment|
|Price of already-built homes in Seattle area drops|
|Apple hits record-high value|
|Fed's ability to regulate questioned|
|Budweiser to move away from Clydesdales|
|Mergers lucrative for departing CEOs, but not necessarily shareholders|
Is your business ready to join us in the call for action? This opening panel includes Oregon businesses who will discuss why they signed the Oregon Climate Declaration, the investments they are making to reduce carbon emissions, and how their actions are affecting their companies.
Get ready for two days of special events produced with the EPA, Portland Timbers and ISOS before and after the GoGreen Conference on October 16.
Plenty of employers seem “dazed and confused” after the recent vote to legalize marijuana. In light of Measure 91 passing, what are some issues for private-sector Oregon employers to consider?
Rotary’s Oregon Ethics in Business aims to raise consciousness about business ethics by honoring exceptional companies.
Barran Liebman’s annual employment law seminar is an industry classic.
Is my drug-free workplace policy up in smoke?
More than 400 "Change Makers" will gather to invest in a socially sustainable community.